Cargando…
Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker
OBJECTIVE: Myasthenia gravis (MG) is a chronic autoimmune disorder where autoantibodies target the nicotinic acetylcholine receptors (AChR+) in about 85% of cases, in which the thymus is considered to play a pathogenic role. As there are no reliable biomarkers to monitor disease status in MG, we ana...
Autores principales: | Punga, Tanel, Le Panse, Rozen, Andersson, Mats, Truffault, Frédérique, Berrih-Aknin, Sonia, Punga, Anna R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207504/ https://www.ncbi.nlm.nih.gov/pubmed/25356381 http://dx.doi.org/10.1002/acn3.24 |
Ejemplares similares
-
Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine
por: Sabre, Liis, et al.
Publicado: (2020) -
Editorial: Advances in Autoimmune Myasthenia Gravis
por: Punga, Anna Rostedt, et al.
Publicado: (2020) -
Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis
por: Cron, Mélanie A., et al.
Publicado: (2019) -
Thymectomy lowers the myasthenia gravis biomarker miR-150-5p
por: Molin, Carl Johan, et al.
Publicado: (2018) -
Decreased expression of miR-29 family associated with autoimmune myasthenia gravis
por: Cron, Mélanie A., et al.
Publicado: (2020)